DuPont's seaweed-based soft capsule ingredient gains non-GMO certification
SeaGel offers drug and dietary supplement manufacturers an animal-free and sustainable alternative to traditional soft capsules.
After scrupulous testing of raw material sourcing and manufacturing, DuPont's SeaGel CAP101 and SeaGel CAP203 non-animal soft capsule technologies achieved Non-GMO Project Verified certification.
SeaGel offers a plant-based alternative to traditional soft capsules. Although soft capsules are a common delivery format for active ingredients, they are traditionally made with gelatin.
Naturally derived from seaweed, SeaGel is animal-free, making it inclusive to vegan, vegetarian, Halal and Kosher diets. Its recent non-GMO designation allows manufacturers incorporating SeaGel into their formulation to appeal to a wider range of consumers.
“As consumers become more informed about what goes into their daily supplements, they’re searching for products that are natural, sustainable and non-GMO,” said Michael Baumann, global strategic marketing manager, DuPont Nutrition & Biosciences. “Adding the iconic non-GMO butterfly to their end products helps manufacturers and brand owners provide customers with immediate assurance that a product aligns with their lifestyle needs.”
SeaGel offers manufacturers solutions to a wide range of formulation challenges, and when compared to alternative vegetarian soft capsule technology, it provides superior sealing performance and reduced leakage.
Since seaweed has a higher melting point than gelatin, SeaGel soft capsules are more heat stable, ensuring they will not become sticky or melt together inside capsule bottles. Its adaptability to shape, color and coating — plus easy incorporation into existing gelatin manufacturing operations — allows for a wide range of brand strategies with minimum capital investment.
Related News
-
News EU-GMP licence positions MediCane Health as possible cannabis export hub
MediCane Health's EU-GMP certification helps to bridge the pharma-cannabis gap -
News Panaxia's medical cannabis facility in Malta gains EU-GMP standard
This second facility gives the company a significant power multiplier for export capacity and geographical reach -
News China SXT's new lyophilisation facility secures pharmaceutical manufacturing permit
The move, coupled with the plants's passing of a pharmaceutical GMP compliance inspection, will enable company to accelerate the R&D of its novel Advanced TCMPs -
News Europe approves SK Bioscience’s global COVID-19 vaccine plant
CDMO's site becomes the first vaccine production facility in South Korea to obtain EU GMP certification, allowing it to ship to Europe -
News Pharma importers forced to reorganise supply chains due to Brexit complications, says medicines trade expert
EU/UK trade deal fell way short of UK’s initial expectations for medicinal products ahead of negotiations, says Peter Gough at NSF International -
News Pharma Explained: What is Quality Assurance?
Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video presenta... -
News 17th Annual CPHI Pharma Awards winners announced
Excellence in Pharma recognised at virtual ceremony taking place at the CPHI Festival of Pharma. -
News Successful MHRA regulatory inspection for Scottish CMO Symbiosis
Inspection conducted remotely using video-conferencing and an online private document sharing platform.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance